Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

NCT02201992

Conditions
ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 1618 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details
Active, Not Recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study

NCT06461338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine. Guangzhou, Guangdong, China
  • Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China
  • Jiangsu Provincial Hospital of Chinese Medicine Nanjing, Jiangsu, China
View Trial Details
Active, Not Recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

NCT06211036

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Infirmary Cancer Center Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
View all 219 locations
View Trial Details
Active, Not Recruiting

Lorlatinib Continuation Study

NCT05144997

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • The First affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details

Related conditions